Related Experiment Video
Updated: Aug 1, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Glomerular Diseases in the Colombian Caribbean: Data from the Colombian Nephropathy Registry (NEFRORED®)
Gustavo Aroca-Martínez1, Henry J González-Torres2, Alex Domínguez-Vargas3
1Faculty of Health Sciences, Simón Bolívar University; Department of Nephrology, Clínica de la Costa, Barranquilla, Colombia.
Insights
This study of Colombian Caribbean kidney biopsies reveals secondary glomerular diseases are more common than primary types. Lupus nephritis was the leading cause of secondary disease.
Area of Science:
- Nephrology
- Pathology
- Epidemiology
Background:
- Glomerular diseases represent a significant cause of kidney disease globally.
- Understanding regional variations in glomerular disease prevalence is crucial for targeted interventions.
- The Colombian Nephropathy Registry (NEFRORED®) provides a unique dataset for this analysis.
Purpose of the Study:
- To characterize the spectrum of primary glomerular disease (PGD) and secondary glomerular disease (SGD) in the Colombian Caribbean.
- To identify the most frequent etiologies within PGD and SGD categories.
- To assess renal survival prognosis in patients with specific glomerular diseases.
Main Methods:
- A descriptive, retrospective study utilizing data from the NEFRORED® registry.
- Analysis of 871 renal biopsies (light microscopy and immunofluorescence) from January 2008 to June 2018.
- Evaluation of clinical indications for biopsy and 24-month renal survival outcomes.
Main Results:
- Secondary glomerular disease (55%) was more prevalent than primary glomerular disease (45%).
- Lupus nephritis was the predominant cause of SGD (83%), while membranous nephropathy (33%) and focal segmental glomerulosclerosis (FSGS) (19%) were most common in PGD.
- Nephritic syndrome was the primary indication for renal biopsy (36%).
- Patients with FSGS and paraproteinemia-mediated glomerular disease exhibited poorer renal survival.
Conclusions:
- The Colombian Caribbean region shows a high predominance of secondary glomerular diseases, largely driven by lupus nephritis.
- This registry represents the first regional data on glomerular diseases in this population.
- FSGS and paraproteinemia-mediated glomerular disease require close monitoring due to adverse renal outcomes.
Abstract:
Our study aimed to describe the glomerular diseases, both primary glomerular disease (PGD) and secondary glomerular disease (SGD) in the Colombian Caribbean based on the first regional Colombian Nephropathy Registry (NEFRORED®). A descriptive and retrospective study of adult patients with glomerular diseases from the Colombian Caribbean region was made. All diagnoses by renal biopsy with light microscopy and immunofluorescence obtained between January 2008 and June 2018 were recorded. Eight hundred and seventy-one renal biopsies were obtained. The main clinical indication for biopsy was nephritic syndrome (36%). SGD was more frequent than PGD (55% vs. 45%). Within SGD group, lupus nephritis (LN) was the most frequent etiology (83%). Within PGD group, membranous nephropathy (33%) and focal segmental glomerulosclerosis (FSGS) (19%) were the most common glomerular diseases. At a 24-month follow-up, the patients with FSGS and paraproteinemia-mediated glomerular disease had the worst renal survival prognosis. This is the first Colombian Nephropathy Registry in a Caribbean population, demonstrating a high predominance of SGD due to LN.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction

